Benznidazole: Hero or villain of cellular immune response in chronic Chagas disease patients?

Soares, Ana K.A.; Neves, Patrícia A.F.; Nascimento, Amanda V.; Esmeraldo, Artur A.M.; Moreira, Leyllane R.; Higino, Taciana M.M.; C.B.Q. Figueiredo, Regina; G.A.M. Cavalcanti, Maria; Martins, Sílvia M.; Carrazone, Cristina; Júnior, Wilson O.; Gomes, Yara M.; Lorena, Virginia M.B..
Artículo en Portugués | ARCA | ID: arc-57641

Documentos relacionados

  1. Does Diabetes Influence Adherence in Glaucoma Patients?
  2. [Is the Patient Dignity Inventory suitable even for not end of life patients? Factorial structure and invariance in chronic patients].
  3. [How do you explain vaccine effects to patients? A representative, web-based survey among primary care physicians from North-Rhine Westphalia].
  4. [Do pain therapy patients benefit from their fellow patients? : A retrospective observational study on the influence of the stage of pain management and therapy experience of fellow patients on the individual therapy success in an inpatient interdisciplinary multimodal pain therapy (IMPT)].
  5. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
  6. ["EVAR First" also in "Fit-for-Open-Repair" Patients? - 'CON' Statement].
  7. [Why do cardiologists disregard sexual health of their patients? A critical review].
  8. [750 satisfied patients? Stapled haemorrhoidopexy (Longo procedure) for the treatment of haemorrhoids and anal canal prolapse: a review of our 10-year experience].
  9. [How do general practitioners evaluate collaborative care of elderly depressed patients? Results of a qualitative study].
  10. Benznidazole: Hero or villain of cellular immune response in chronic Chagas disease patients?